Health Economics

Does the net health benefit outweigh the cost of screening?

CF and SMA are recommended for pan-ethnic screening but account for only 17% of at-risk couples detected by Counsyl Foresight™ Carrier Screen. We expect that further adoption of ECS will likely provide net savings to the healthcare system.

Carrier screening by next-generation sequencing: health benefits and cost effectiveness.

Molecular Genetics & Genomic Medicine. 2016;4(3):292-302. doi:10.1002/mgg3.204 Azimi M, Schmaus K, Greger V, Neitzel D, Rochelle R, Dinh T.

Understanding the Costs of Care for Cystic Fibrosis: An Analysis by Age and Health State.

  • Value in Health. 2013;16(2):345-355. doi:10.1016/j.jval.2012.12.003
  • van Gool K, Norman R, Delatycki M, Hall J, Massie J.

PGD for all cystic fibrosis carrier couples: novel strategy for preventive medicine and cost analysis.

Reproductive BioMedicine Online. 2010;21(2):186-195. doi:10.1016/j.rbmo.2010.04.031 Tur-Kaspa I, Aljadeff G, Rechitsky S, Grotjan H, Verlinsky Y.